Results 21 to 30 of about 5,421,945 (243)
Rituximab in the treatment of Graves’ orbitopathy: latest updates and perspectives
Endocrine Connections, 2022 Graves’ orbitopathy (GO) is a potentially sight-threatening and disfiguring, extrathyroidal manifestation of Graves’ disease. It often impairs patients’ qu ality of life, causing severe social and psychological sequelae.
Jakub Supronik +3 more
doaj +1 more source
The rs1990760 polymorphism within the IFIH 1 locus is not associated with Graves' disease, Hashimoto's thyroiditis and Addison's disease [PDF]
, 2009 Background: Three genes have been confirmed as major joint susceptibility genes for endocrine autoimmune disease:human leukocyte antigen class II, cytotoxic T-lymphocyte antigen 4 and protein tyrosine phosphatase non-receptor type 22.
Reisch, Nicole +30 more
core +1 more source
Radioiodine treatment for graves’ disease: a 10-year Australian cohort study
BMC Endocrine Disorders, 2018 Background Radioactive iodine (I131) is a common definitive treatment for Graves’ Disease. Potential complications include worsening, or new development of Graves’ eye disease and development of a radiation thyroiditis.
Erin Fanning +2 more
doaj +1 more source
A case report of immune thrombocytopenic purpura as a rare Harbinger of Graves’ disease
Journal of Clinical and Translational Endocrinology Case Reports, 2022 Graves’ disease is one of the most common forms of autoimmune hyperthyroidism and has been linked with multiple or family histories of autoimmune diseases. In most cases, Graves' disease diagnosis is easily made by recognizing goiter, ophthalmopathy, and
Handoko Hariyono, Jongky Hendro Prajitno
doaj +1 more source
Surgical treatment for Graves’ disease
Hong Kong Journal of Ophthalmology, 2017 Surgical treatment for Gravesâ ...
Vivian Man, Brian Hung Hin Lang
openaire +1 more source
JOURNAL OF ADVANCES IN BIOTECHNOLOGY, 2015 Disturbed antioxidant enzymes activities was known to be associated to Auto-Immune Thyroid Diseases (AITD), but it is noteworthy that the selenoenzyme glutathione peroxidase (GPx) showed the lowest activity and a selenium (Se) deficiency may be the major cause. Most studies conducted on AITD are focused on the effect of the Se supplementation on the ...
Saloua LASSOUED +6 more
openaire +1 more source
A Genomic Point Mutation in the Extracellular Domain of the Thyrotropin Receptor in Patients with Graves’ Ophthalmopathy [PDF]
, 1994 Orbital and pretibial fibroblasts are targets of autoimmune attack in Graves' ophthalmopathy (GO) and pretibial dermopathy (PTD). The fibroblast autoantigen involved in these peripheral manifestations of Graves' disease and the reason for the association
Sarkar, Gobinda +4 more
core +1 more source
Thyroid Research, 2019 Background Treatment of moderate to severe Graves’ orbitopathy (GO) is based mainly on intravenous pulses of methylprednisolone. High doses of methylprednisolone can exert several adverse effects, some of which might be life-threatening. The objective of
Dorota Walasik-Szemplińska +2 more
doaj +1 more source
Graves' Disease that Developed Shortly after Surgery for Thyroid Cancer [PDF]
Endocrinology and Metabolism, 2013 Graves' disease is an autoimmune disorder that may present with various clinical manifestations of hyperthyroidism. Patients with Graves' disease have a greater number of thyroid nodules and a higher incidence of thyroid cancer compared with patients ...
Hea Min Yu +3 more
doaj +1 more source
, 2018 Additional file 1: Table S1. The predicted candidate gene, pathway and related other inflammatory disease of the selected microRNA candidates.
Chen, Xinxin +8 more
openaire +1 more source